IQVIA HOLDINGS Kurzporträt
- Entwicklung von Lösungen und Dienstleistungen für Auftragsforschung und klinische Entwicklung (54,5%): Unterstützung von biopharmazeutischen Unternehmen, medizinischen Forschern und Fachleuten des Gesundheitswesens bei der Optimierung ihrer klinischen Studien, der Entwicklung neuer therapeutischer Klassen, der Ermittlung des Behandlungsbedarfs und der Bewertung der Wirksamkeit von Arzneimitteln im Hinblick auf die Verbesserung der klinischen und wissenschaftlichen Ergebnisse;
- Entwicklung von Technologie- und Analyselösungen (39.9%): Dienstleistungen im Zusammenhang mit Informationen, Analysen, strategischer Beratung, Marketingstudien und kurzfristigen Studien zum Gesundheitsmarkt, Outsourcing von Geschäftsprozessen und Verwaltung von medizinisch-administrativen Datenbanken, die alle darauf abzielen, die Leistung und die kommerziellen Strategien von Pharmaunternehmen und Gesundheitsdienstleistern zu optimieren;
- integrierte Dienstleistungen (5,6%): Entwicklung und Umsetzung von maßgeschneiderten Lösungen und Kundenbindungsprogrammen, Gesundheitsdienstleistungen, wissenschaftliche und medizinische Dienstleistungen usw.
Der Nettoumsatz verteilt sich geographisch wie folgt: Amerika (49,4%), Europa und Afrika (31,4%) und Asien/Pazifik (19,2%).
Umsatz nach Geschäftsbereich
| USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
|---|---|---|---|---|---|
Research and Development Solutions
56,0
%
| 7 921 | 55,0 % | 8 395 | 56,0 % | +5.98% |
Technology and Analytics Solutions
39,1
%
| 5 746 | 39,9 % | 5 862 | 39,1 % | +2.02% |
Contract Sales and Medical Solutions
4,9
%
| 743 | 5,2 % | 727 | 4,9 % | -2.15% |
Umsatz je Region
| USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
|---|---|---|---|---|---|
United States
45,0
%
| 6 052 | 42,0 % | 6 743 | 45,0 % | +11.41% |
Europe and Africa
29,8
%
| 4 366 | 30,3 % | 4 459 | 29,8 % | +2.13% |
Asia-Pacific
19,8
%
| 2 996 | 20,8 % | 2 973 | 19,8 % | -0.77% |
Americas
5,4
%
| 996 | 6,9 % | 809 | 5,4 % | -18.74% |
Manager
| Manager | Titel | Alter | Seit |
|---|---|---|---|
Ari Bousbib
CEO | Chief Executive Officer | 63 | 03.10.16 |
Ronald Bruehlman
DFI | Director of Finance/CFO | 63 | 01.08.20 |
James Berkshire
COO | Chief Operating Officer | 51 | 01.07.17 |
Jeffrey Spaeder
CTO | Chief Tech/Sci/R&D Officer | - | - |
Karl Guenault
CTO | Chief Tech/Sci/R&D Officer | - | 01.11.17 |
W. Staub
CTO | Chief Tech/Sci/R&D Officer | 61 | 01.11.16 |
Nick Childs
IRC | Investor Relations Contact | - | 01.04.21 |
| Comptroller/Controller/Auditor | 40 | 01.03.19 | |
Joanne Hackett
PRN | Corporate Officer/Principal | 45 | - |
Michael Stibilj
PRN | Corporate Officer/Principal | 55 | 01.07.17 |
Aufsichtsräte
| Aufsichtsräte | Titel | Alter | Seit |
|---|---|---|---|
John Danhakl
BRD | Director/Board Member | 67 | 03.10.16 |
Colleen Goggins
BRD | Director/Board Member | 68 | 27.07.17 |
Ari Bousbib
CEO | Chief Executive Officer | 63 | 03.10.16 |
John Connaughton
BRD | Director/Board Member | 58 | 01.01.08 |
Jim Fasano
BRD | Director/Board Member | 54 | 03.10.16 |
John Leonard
BRD | Director/Board Member | 66 | 05.02.15 |
Todd Sisitsky
BRD | Director/Board Member | 52 | 01.01.16 |
Carol Burt
BRD | Director/Board Member | 66 | 21.02.19 |
Sheila Stamps
BRD | Director/Board Member | 66 | 26.01.22 |
Leslie Morris
BRD | Director/Board Member | 53 | 24.01.22 |
Anteilsklasse
| Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
|---|---|---|---|---|---|
| Aktie A | 1 | 257 900 000 | 180 519 606 ( 70,00 %) | 75 700 000 ( 29,35 %) | 70,00 % |
Unternehmenskontakt
Konzerngesellschaften
| Name | Kategorie und Branche |
|---|---|
Aecio IT Solutions India Pvt Ltd.
| |
Data Processing Services
| |
IMS Health BV
| |
IQVIA Ltd.
 IQVIA Ltd. Information Technology ServicesTechnology Services IQVIA Ltd. provides professional services, information and partnering solutions. The firm serves its services to pharmaceutical, biotechnology, medical device and healthcare industries. It also provides contract research, sales, marketing, healthcare policy consulting and health information management services. The company was founded by Dennis Barry Gillings in 1995 and is headquartered in Reading, the United Kingdom. |
Information Technology Services
|
Q Squared Solutions (India) Pvt Ltd.
 Q Squared Solutions (India) Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2015, Q Squared Solutions (India) Pvt Ltd. is a business services company. Part of IQVIA Holdings, Inc., the company is based in Mumbai, India. |
Miscellaneous Commercial Services
|
Excel Life Sciences Pvt Ltd.
| |
Quintiles Phase One Clinical Trials India Pvt Ltd.
| |
MediNeos Srl
 MediNeos Srl Miscellaneous Commercial ServicesCommercial Services MediNeos Srl operates as a contract research organization specialized in the design and conduct of observational studies. The firm provides strategic consultancy, feasibility studies, site management and clinical monitoring, data management, and international project management services. The company was founded by Giovanni Fiori in 2003 and is headquartered in Modena, Italy. |
Miscellaneous Commercial Services
|
IQVIA RDS Italy Srl
 IQVIA RDS Italy Srl Miscellaneous Commercial ServicesCommercial Services Part of IQVIA Holdings, Inc., IQVIA RDS Italy Srl is a company based in Milan, Italy that offers comprehensive and flexible solutions to help life sciences organizations drive healthcare forward and get the right treatments to patients faster. The Italian company provides innovative pharmacovigilance solutions powered by the IQVIA core, which includes integrated, scalable technologies combined with data, advanced analytics, and deep domain expertise. The company's solutions include dynamic monitoring of structured and unstructured data, single platform source data verification, enablement of decentralized trials, intuitive and automated functionality to improve data quality, audit-ready clinical trials, stronger partnerships between subjects, sites, and sponsors, and interoperable solutions that connect with internal systems and their suite of products. Additionally, IQVIA RDS Italy offers expertise across the generics lifecycle to navigate the complex patent landscape and maximize opportunity. |
Miscellaneous Commercial Services
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
| % 1. Jan. | Kap. | |
|---|---|---|
| +41.79% | 54.04 Mrd. | |
| +47.58% | 41.96 Mrd. | |
| -7.20% | 28.35 Mrd. | |
| +12.59% | 26.35 Mrd. | |
| -21.51% | 19 Mrd. | |
| +6.92% | 13 Mrd. | |
| +24.91% | 12.19 Mrd. | |
| +29.60% | 12.28 Mrd. | |
| -5.64% | 11.49 Mrd. |
